Inventor · disambiguated record
Sarah K. Knutson
Also filed as: KNUTSON SARAH K · KNUTSON SARAH KATHLEEN
31 granted patents·30 pending applications·563 citations·filing 2011–2024
98Inventor score
Top patents by PatentIndex Score
61 records- 0198US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 0298US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 0398US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 0498US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 0597US11642349B2Method for treating cancerEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·11 claims
- 0697US11370781B2Combination therapy for treating cancerEPIZYME INC·Filed 2020·Granted Jun 28, 2022·4 cites·20 claims
- 0797US9334527B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2014·Granted May 10, 2016·39 cites·13 claims
- 0896US11951109B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2021·Granted Apr 9, 2024·4 cites·14 claims
- 0996US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 1096US10787440B2Combination therapy for treating cancerEPIZYME INC·Filed 2019·Granted Sep 29, 2020·8 cites·20 claims
- 1196US10493076B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Dec 3, 2019·7 cites·22 claims
- 1296US10301290B2Combination therapy for treating cancerEPIZYME INC·Filed 2013·Granted May 28, 2019·13 cites·9 claims
- 1396US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 1496US9855275B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Jan 2, 2018·18 cites·30 claims
- 1596US9688665B2Methods of treating cancerEPIZYME INC·Filed 2013·Granted Jun 27, 2017·23 cites·16 claims
- 1696US9175331B2Inhibitors of human EZH2, and methods of use thereofKUNTZ KEVIN WAYNE·Filed 2012·Granted Nov 3, 2015·46 cites·8 claims
- 1796US8691507B2Inhibitors of human EZH2 and methods of use thereofEPIZYME INC·Filed 2013·Granted Apr 8, 2014·40 cites·12 claims
- 1895US11642347B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2020·Granted May 9, 2023·6 cites·10 claims
- 1995US11202781B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2019·Granted Dec 21, 2021·8 cites·14 claims
- 2095US10420775B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Sep 24, 2019·12 cites·20 claims
- 2194US10463671B2Combination therapy for treating cancerEPIZYME INC·Filed 2017·Granted Nov 5, 2019·12 cites·25 claims
- 2294US9333217B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2014·Granted May 10, 2016·23 cites·6 claims
- 2393US8895245B2Inhibitors of human EZH2 and methods of use thereofCOPELAND ROBERT A·Filed 2011·Granted Nov 25, 2014·42 cites·8 claims
- 2492US12168015B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·2 claims
- 2592US12161645B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 10, 2024·0 cites·10 claims
- 2692US9949999B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2016·Granted Apr 24, 2018·10 cites·17 claims
- 2791US12168016B2Aryl-OR heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·12 claims
- 2891US10166238B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2015·Granted Jan 1, 2019·12 cites·19 claims
- 2991US2025170138A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Application pending·0 cites
- 3090US10898490B2Method for treating cancerEPIZYME INC·Filed 2019·Granted Jan 26, 2021·5 cites·11 claims
- 3190US9376422B2Dihidropyridin-2-one benzamine compoundsKUNTZ KEVIN WAYNE·Filed 2012·Granted Jun 28, 2016·16 cites·19 claims
- 3290US2025163033A1Methods of treating cancerEPIZYME INC·Filed 2024·Application pending·0 cites
- 3387US2025109123A1Combination therapy for treating cancerEPIZYME INC·Filed 2024·Application pending·0 cites
- 3483US12162865B2Methods of treating cancerEPIZYME INC·Filed 2022·Granted Dec 10, 2024·0 cites·14 claims
- 3581US2024024331A1Method for treating cancerEPIZYME INC·Filed 2023·Application pending·0 cites
- 3680US2024058348A1Ezh2 inhibitors for treating lymphomaEPIZYME INC·Filed 2023·Application pending·0 cites
- 3779US2022281854A1Combination therapy for treating cancerEPIZYME INC·Filed 2022·Application pending·0 cites
- 3878US2021379076A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2021·Application pending·0 cites
- 3978US2022218714A1Method of treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 4075US2022226336A1Combination therapy for treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 4173US2020397812A1Inhibitors of human ezh2, and methods of use thereofEPIZYME INC·Filed 2020·Application pending·0 cites
- 4270US2020262823A1Methods of treating cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 4370US2020330472A1Method of treating cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 4466US2019100514A1Methods of treating cancerEPIZYME INC·Filed 2018·Application pending·0 cites
- 4565US2019240230A1Method of treating cancerEPIZYME INC·Filed 2019·Application pending·0 cites
- 4665US2020016162A1Inhibitors of human ezh2, and methods of use thereofEPIZYME INC·Filed 2019·Application pending·0 cites
- 4764US2020113911A1Combination therapy for treating cancerEPIZYME INC·Filed 2019·Application pending·0 cites
- 4864US2016228447A1Method of treating cancerEPIZYME INC·Filed 2014·Application pending·0 cites
- 4963US2016303135A1Combination therapy for treating cancerEPIZYME INC·Filed 2014·Application pending·0 cites
- 5063US2020022987A1Ezh2 inhibitors for treating lymphomaEPIZYME INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →